Patient-reported outcomes in relapsed or refractory large B-cell lymphoma revealed that receiving CAR T-cell immunotherapy was associated with higher quality of life, according to a recent study.
Browsing: Clinical Breakthroughs
A team of Northwestern investigators led by Peter Penzes, PhD, has developed a new therapy that could treat Phelan-McDermid syndrome, a subtype of autism spectrum disorder.
Non-white racial and ethnic groups are underrepresented in OB-GYN clinical trials, according to a new Northwestern Medicine study.
Investigators have developed a novel personalized T-cell therapy approach that may identify specific targets unique to a patient’s cancer cells more effectively than current treatments, according to findings published in Nature.
A recent parent survey has identified intergenerational trends in swimming skills, with stark racial and ethnic differences.
A new study has shown that vitamin D supplements do not reduce muscle pain associated with statin drugs.
Even before COVID-19, emergency departments experienced a spike in visits for youth with suicidal thoughts or ideas, according to a recent study.
The Robert H. Lurie Comprehensive Cancer Center of Northwestern University will begin scaling up its collection and use of data related to patient sex assigned at birth, gender identity, and sexual orientation with funding from the National Cancer Institute.
Telmisartan, an angiotensin receptor blocker drug, did not improve walking performance in patients with lower extremity peripheral artery disease, according to a recent clinical trial published in JAMA.
There is significant variation in the prevalence of obesity among subgroups of Asian American adults, according to a recent Northwestern Medicine study.